Skip to main content

Table 3 Cell surface markers of DC+AK and TIL

From: Eradication of intractable malignant ascites by abdominocentesis, reinfusion of concentrated ascites, and adoptive immunotherapy with dendritic cells and activated killer cells in a patient with recurrent lung cancer: a case report

 

DC+AK

TIL

CD3

99.2

98.9

CD8

38.2

97.3

CD4

68.2

7

HLA-DR

97.9

95.7

CD83

19.1

2